comparemela.com

Page 7 - Naval Daver News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ImmunoGen Announces Results from the Phase 3 MIRASOL Trial Selected as Late-Breaking Presentation for ASCO 2023 Annual Meeting

Faron Pharmaceuticals Limited plans to host virtual event in novel immunotherapies development

Faron Pharmaceuticals Limited plans to host virtual event in novel immunotherapies development
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Risk Classification, Mutational Analysis Are Key in Informing AML Management

During an OncLive® workshop titled Key Updates in the Management of Acute Myeloid Leukemia and Their Application in Clinical Practice, moderated by Naval Daver, MD, faculty reviewed updates to the classification of acute myeloid leukemia and its effects on the treatment paradigm and provided insight on the management of adverse-risk and secondary acute myeloid leukemia.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.